Remove Acquisition Remove Capital Remove Development Remove Enterprise Partners
article thumbnail

XIFIN Buys PathCentral

socalTECH

San Diego-based XIFIN , which develops cloud-based financial software for the healthcare industry, has acquired Irvine-based PathCentral , a developer of software for the pathology community, the company announced Thursday afternoon. Financial details of the acquisition were not announced. READ MORE>>.

Windward 138
article thumbnail

Celladon Files For IPO

socalTECH

San Diego-based Celladon , a clinical stage biopharmaceuticals firm which is developing enzymes to address calcium regulation, has filed for an IPO. Celladon is backed by Enterprise Partners, Pfizer, Lundbeckfond, Novartis Bioventures, J&J Development, GBS Bioventures, MPM Capital, Venrock, H&Q, as well as others.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

XIFIN Acquired By GTCR

socalTECH

San Diego-based XIFIN , a developer of cloud-based software for the healthcare diagnostics market, has been acquired by private equity investor GTCR. billion GTCR Fund XI, with additional funding provided by GE Capital and CapitalSource. XIFIN''s backers include Boulder Ventures, Enterprise Partners, and Windward Ventures.

Windward 138
article thumbnail

TargeGen Acquired By Sanofi-aventis

socalTECH

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. Tags: targegen sanofi aventis merger acquisition lifescience bioscience.